- 78% Business intelligence for bio/pharma drugs – DrugPatentWatch

Business intelligence for bio/pharma drugs – DrugPatentWatch

Add your review
  • All prices mentioned above are in United States dollar.
  • This product is available at Udemy.
  • At udemy.com you can purchase Business intelligence for bio/pharma drugs - DrugPatentWatch for only $44.99
  • The lowest price of Business intelligence for bio/pharma drugs - DrugPatentWatch was obtained on December 15, 2024 11:50 pm.

Original price was: $44.99.Current price is: $10.00.

Best deal at: udemy.comudemy.com
Buy for best price
Set Lowest Price Alert
×
Notify me, when price drops
Set Alert for Product: Business intelligence for bio/pharma drugs - DrugPatentWatch - $44.99
Price history
×
Price history for Business intelligence for bio/pharma drugs - DrugPatentWatch
Latest updates:
  • $44.99 - December 15, 2024
  • $10.00 - November 24, 2024
Since: November 24, 2024
  • Highest Price: $44.99 - December 15, 2024
  • Lowest Price: $10.00 - November 24, 2024
Add to wishlistAdded to wishlistRemoved from wishlist 0
Last updated on December 15, 2024 11:50 pm
Business intelligence for bio/pharma drugs – DrugPatentWatch
Business intelligence for bio/pharma drugs – DrugPatentWatch

Original price was: $44.99.Current price is: $10.00.

Description

Price history for Business intelligence for bio/pharma drugs - DrugPatentWatch
Latest updates:
  • $44.99 - December 15, 2024
  • $10.00 - November 24, 2024
Since: November 24, 2024
  • Highest Price: $44.99 - December 15, 2024
  • Lowest Price: $10.00 - November 24, 2024

Didn't find the right price? Set price alert below

Set Alert for Product: Business intelligence for bio/pharma drugs - DrugPatentWatch - $44.99

Business intelligence for bio/pharma drugs - DrugPatentWatch

★★★★★
$44.99  in stock
Udemy.com
as of December 15, 2024 11:50 pm

Transform Data into Market Domination -- Finding and Evaluating Generic and Branded Drug Opportunties (FREE TEXTBOOK)

Created by: Yali Friedman, Ph.D.
Publisher, DrugPatentWatch
Rating:4.34 (107reviews)     469students enrolled

What Will I Learn?

  • Finding and evaluating generic drug market entry opportunities
  • Branded drug lifecycle management
  • Find generic drug entry opportunities
  • Track drugs in development and explore new indications for existing drugs
  • Study failed patent challenges to develop a better strategy
  • Collect competitive intelligence by examining contractual disputes
  • Track litigation to anticipate early generic entry
  • Find and evaluate business opportunities
  • Assess levels of generic competition
  • Use drug price ranges to evaluate price elasticity
  • Determine optimal prices before launch
  • Evaluate buyer power with data on reimbursement segmentation
  • Align distribution methods with information on where and how drugs are purchased
  • Evaluate branded and generic market opportunities globally
  • Anticipate 505(b)(2) and biosimilar approvals
  • Strengthen new formulation patents by studying prior claims and litigation
  • Adapt your gmp facility to capture changes in demand with brand erosion and generic launches as drug patents expire
  • Position regulatory affairs to capture emerging opportunities
  • Understand the roles of patents, trade secrets, trademark, and other forms of intellectual property protection in protecting branded pharmaceutical and biotechnology drugs
  • Proactively adapt sourcing, purchasing, and supply chain management to anticipate changes in supply and demand with generic drug entry

Requirements

  • basic understanding of the pharmaceutical industry

Target audience

  • Generic pharmaceutical company portfolio managers
  • Branded drug lifecycle management, sourcing, procurement, and supply chain professionals
  • Pharmaceutical drug analysts, investment analysts, and patent analysts
  • Patent analysts
  • Patent Landscape Profilers
  • Biotech and Pharma Investors
  • Supply chain, sourcing, purchasing managers, procurement, wholesalers, distributors, and warehouses
  • Good Manufacturing Practice (GMP) facility owners and operators
  • Pharmaceutical regulatory affairs professionals, lawyers, consultants, and founders
  • Drug and medical device development managers

Price History

Price history for Business intelligence for bio/pharma drugs - DrugPatentWatch
Latest updates:
  • $44.99 - December 15, 2024
  • $10.00 - November 24, 2024
Since: November 24, 2024
  • Highest Price: $44.99 - December 15, 2024
  • Lowest Price: $10.00 - November 24, 2024

Reviews (0)

User Reviews

0.0 out of 5
0
0
0
0
0
Write a review

There are no reviews yet.

Be the first to review “Business intelligence for bio/pharma drugs – DrugPatentWatch”

Your email address will not be published. Required fields are marked *

Best Sellers News